Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Histone deacetylase mediated transcriptional activation reduces proviral loads in HTLV-1 associated myelopathy/tropical spastic paraparesis patients.
Lezin A, Gillet N, Olindo S, Signaté A, Grandvaux N, Verlaeten O, Belrose G, de Carvalho Bittencourt M, Hiscott J, Asquith B, Burny A, Smadja D, Césaire R, Willems L. Lezin A, et al. Among authors: cesaire r. Blood. 2007 Nov 15;110(10):3722-8. doi: 10.1182/blood-2007-04-085076. Epub 2007 Aug 23. Blood. 2007. PMID: 17717136 Free article.
Gene activation therapy: from the BLV model to HAM/TSP patients.
Lezin A, Olindo S, Belrose G, Signate A, Cesaire R, Smadja D, Macallan D, Asquith B, Bangham C, Bouzar A, Gillet N, Defoiche J, Florins A, Verlaeten O, Burny A, Willems L. Lezin A, et al. Among authors: cesaire r. Front Biosci (Schol Ed). 2009 Jun 1;1(1):205-15. doi: 10.2741/S20. Front Biosci (Schol Ed). 2009. PMID: 19482696 Free article. Review.
Absence of consistent association between human leukocyte antigen-I and -II alleles and human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis risk in an HTLV-1 French Afro-Caribbean population.
Deschamps R, Béra O, Belrose G, Lezin A, Bellance R, Signate A, Cabre P, Smadja D, Césaire R, Olindo S. Deschamps R, et al. Among authors: cesaire r. Int J Infect Dis. 2010 Nov;14(11):e986-90. doi: 10.1016/j.ijid.2010.05.020. Epub 2010 Sep 17. Int J Infect Dis. 2010. PMID: 20851016 Free article.
Effects of valproate on Tax and HBZ expression in HTLV-1 and HAM/TSP T lymphocytes.
Belrose G, Gross A, Olindo S, Lézin A, Dueymes M, Komla-Soukha I, Smadja D, Tanaka Y, Willems L, Mesnard JM, Peloponese JM Jr, Césaire R. Belrose G, et al. Among authors: cesaire r. Blood. 2011 Sep 1;118(9):2483-91. doi: 10.1182/blood-2010-11-321364. Epub 2011 Apr 19. Blood. 2011. PMID: 21505188 Free article.
Safety of long-term treatment of HAM/TSP patients with valproic acid.
Olindo S, Belrose G, Gillet N, Rodriguez S, Boxus M, Verlaeten O, Asquith B, Bangham C, Signaté A, Smadja D, Lezin A, Césaire R, Willems L. Olindo S, et al. Among authors: cesaire r. Blood. 2011 Dec 8;118(24):6306-9. doi: 10.1182/blood-2011-04-349910. Epub 2011 Oct 13. Blood. 2011. PMID: 21998206 Free article. Clinical Trial.
Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay.
Dehée A, Césaire R, Désiré N, Lézin A, Bourdonné O, Béra O, Plumelle Y, Smadja D, Nicolas JC. Dehée A, et al. Among authors: cesaire r. J Virol Methods. 2002 Apr;102(1-2):37-51. doi: 10.1016/s0166-0934(01)00445-1. J Virol Methods. 2002. PMID: 11879691
114 results